SCHEMBL19783655

SCHEMBL19783655

COc1c(F)c(Cl)cc2sc(N)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
LMNA P02545 2/20 0.49
CYP3A4 P08684 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
HSD17B10 Q99714 2/20 0.41
PDE10A Q9Y233 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
NSD1 Q96L73 2/20 0.36
AXL P30530 1/20 0.35
GFER P55789 1/20 0.35
MAPT P10636 1/20 0.34
FTO Q9C0B1 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
NSD2 O96028 1/20 0.33
NSD3 Q9BZ95 1/20 0.33
PIK3CD O00329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21395396 0.84 ALDH1A1 (0.65) ALDH1A1LMNACYP3A4TDP1HSD17B10
SCHEMBL21395696 0.83 ALDH1A1 (0.50) ALDH1A1LMNACYP3A4TDP1HSD17B10
SCHEMBL21091712 0.83 ALDH1A1 (0.50) ALDH1A1LMNACYP3A4TDP1HSD17B10
SCHEMBL19782658 0.83 ALDH1A1 (0.30) ALDH1A1
SCHEMBL21395694 0.78 ALDH1A1 (0.45) ALDH1A1LMNACYP3A4TDP1HSD17B10
SCHEMBL23480257 0.77 ALDH1A1 (0.54) ALDH1A1LMNACYP3A4TDP1HSD17B10
SCHEMBL27051917 0.77 ALDH1A1 (0.46) ALDH1A1LMNACYP3A4TDP1HSD17B10
SCHEMBL11228174 0.76 LMNA (0.53) ALDH1A1LMNACYP3A4TDP1HSD17B10
SCHEMBL29513993 0.76 ALDH1A1 (0.53) ALDH1A1LMNACYP3A4TDP1HSD17B10
SCHEMBL25347414 0.76 ALDH1A1 (0.53) ALDH1A1LMNACYP3A4TDP1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 ALDH1A1 1618/4885LMNA 745/4885CYP3A4 15/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 ALDH1A1 1598/4885LMNA 603/4885CYP3A4 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.